Drugs / Next Generation ORS
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT05814042 | Aug 2023 → Dec 2024 | cholera, diarrheal disease | University of Florida | Completed | Missed primary |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Next Generation ORS | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05814042 ↗ |
| Route | Oral | “Oral Rehydration Solution (ORS) is currently the only oral therapy” NCT05814042 ↗ |